Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
BMC Infectious Diseases, 06/01/2012Miyashita N et al.
The prevalence of macrolide–resistant M. pneumoniae is high among adolescent patients as well as pediatric patients less than 16–years old. To prevent outbreaks of M. pneumoniae infection, especially macrolide–resistant M. pneumoniae, in closed populations including among families, in schools and in university students, physicians should pay close attention to macrolide–resistant M. pneumoniae.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.